Rising Cases of Identification of Drug of Abuse Testing is Propelling the Overall Market
Industry: Healthcare
Published Date: March-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 169
Report ID: PMRREP9707
1. Executive Summary
1.1. North America Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Adoption Rate/Usage Analysis - Key Statistics
4.2. Value Chain Analysis
4.3. Regulatory Scenario
4.4. Product USP Analysis
4.5. Pipeline Assessment
4.6. PESTEL Analysis
4.7. Porter’s Analysis
4.8. Key Promotional Strategies, By Key Players
5. Market Background
5.1. Macro-Economic Factors
5.1.1. North America GDP Growth Outlook
5.1.2. North America Healthcare Outlook
5.1.3. North America Drug Abuse Testing Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Product Adoption Rate
5.2.2. Prevalence of Chronic Diseases
5.2.3. Strategic Collaborations
5.2.4. Adoption Rate
5.2.5. Cost of Product
5.2.6. Treatment Regime
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Drug Class
6.1.2. By Product
6.1.3. By Sample
6.1.4. By End User
6.1.5. By Country
6.2. 2022 Market Scenario
7. North America Toxicology Laboratories Market Demand (in Value US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Drug Class
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis, by Drug Class, 2016-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Drug Class, 2023-2033
8.3.1. Alcohol
8.3.2. Amphetamines
8.3.3. Barbiturates
8.3.4. Benzodiazepines
8.3.5. Illicit Drugs
8.3.6. Opiates/Opioids
8.3.7. Tricyclic’s Antidepressants
8.3.8. Z Drugs
8.4. Market Attractiveness Analysis, by Drug Class
9. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, by Product, 2016-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033
9.3.1. Reagent and Kits
9.3.1.1. ELISA
9.3.1.2. PCR
9.3.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
9.3.1.4. Radio Immuno-sorbent Assay (RIA)
9.3.2. Instruments
9.3.2.1. Immunochemistry Analyzers
9.3.2.2. PCR Machine
9.3.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
9.3.2.4. High Performance Liquid Chromatography(HPLC)
9.4. Market Attractiveness Analysis, by Product
10. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Sample
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, by Sample, 2016-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Sample, 2023-2033
10.3.1. Urine
10.3.2. Blood
10.3.3. Hair
10.3.4. Oral Fluid
10.4. Market Attractiveness Analysis, by Sample
11. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2016-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2023-2033
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Diagnostic Laboratories
11.3.4. Forensic Laboratories
11.3.5. Rehabilitation Centers
11.4. Market Attractiveness Analysis, by End User
12. North America Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033, By Country
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis, by Country, 2016-2022
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Country 2023-2033
12.3.1. U.S.
12.3.2. Canada
12.4. Market Attractiveness Analysis, by Country
13. U.S. Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2016-2022
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
13.3.1. By Drug Class
13.3.2. By Product
13.3.3. By Sample
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Drug Class
13.4.2. By Product
13.4.3. By Sample
13.4.4. By End User
14. Canada Toxicology Laboratories Market Analysis 2016-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2016-2022
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
14.3.1. By Drug Class
14.3.2. By Product
14.3.3. By Sample
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Drug Class
14.4.2. By Product
14.4.3. By Sample
14.4.4. By End User
15. Market Structure Analysis
15.1. Market Analysis, by Tier of Companies
15.2. Market Share Analysis of Top Players
15.3. Market Concentration
15.4. Market Presence Analysis
16. Competition Analysis
16.1. Competition Dashboard
16.2. Competition Deep Dive
16.2.1. Thermo Fisher Scientific, Inc.
16.2.1.1. Overview
16.2.1.2. Product Portfolio
16.2.1.3. Sales Footprint
16.2.1.4. Key Financials
16.2.1.5. SWOT Analysis
16.2.1.6. Strategy Overview
16.2.1.6.1. Marketing Strategy
16.2.1.6.2. Product Strategy
16.2.1.6.3. Channel Strategy
16.2.2. Danaher Corporation
16.2.2.1. Overview
16.2.2.2. Product Portfolio
16.2.2.3. Sales Footprint
16.2.2.4. Key Financials
16.2.2.5. SWOT Analysis
16.2.2.6. Strategy Overview
16.2.2.6.1. Marketing Strategy
16.2.2.6.2. Product Strategy
16.2.2.6.3. Channel Strategy
16.2.3. Agilent Technologies
16.2.3.1. Overview
16.2.3.2. Product Portfolio
16.2.3.3. Sales Footprint
16.2.3.4. Key Financials
16.2.3.5. SWOT Analysis
16.2.3.6. Strategy Overview
16.2.3.6.1. Marketing Strategy
16.2.3.6.2. Product Strategy
16.2.3.6.3. Channel Strategy
16.2.4. Alere, Inc
16.2.4.1. Overview
16.2.4.2. Product Portfolio
16.2.4.3. Sales Footprint
16.2.4.4. Key Financials
16.2.4.5. SWOT Analysis
16.2.4.6. Strategy Overview
16.2.4.6.1. Marketing Strategy
16.2.4.6.2. Product Strategy
16.2.4.6.3. Channel Strategy
16.2.5. Bio Rad Laboratories Inc
16.2.5.1. Overview
16.2.5.2. Product Portfolio
16.2.5.3. Sales Footprint
16.2.5.4. Key Financials
16.2.5.5. SWOT Analysis
16.2.5.6. Strategy Overview
16.2.5.6.1. Marketing Strategy
16.2.5.6.2. Product Strategy
16.2.5.6.3. Channel Strategy
16.2.6. Neogen Corporation
16.2.6.1. Overview
16.2.6.2. Product Portfolio
16.2.6.3. Sales Footprint
16.2.6.4. Key Financials
16.2.6.5. SWOT Analysis
16.2.6.6. Strategy Overview
16.2.6.6.1. Marketing Strategy
16.2.6.6.2. Product Strategy
16.2.6.6.3. Channel Strategy
16.2.7. Bruker
16.2.7.1. Overview
16.2.7.2. Product Portfolio
16.2.7.3. Sales Footprint
16.2.7.4. Key Financials
16.2.7.5. SWOT Analysis
16.2.7.6. Strategy Overview
16.2.7.6.1. Marketing Strategy
16.2.7.6.2. Product Strategy
16.2.7.6.3. Channel Strategy
16.2.8. WATERS
16.2.8.1. Overview
16.2.8.2. Product Portfolio
16.2.8.3. Sales Footprint
16.2.8.4. Key Financials
16.2.8.5. SWOT Analysis
16.2.8.6. Strategy Overview
16.2.8.6.1. Marketing Strategy
16.2.8.6.2. Product Strategy
16.2.8.6.3. Channel Strategy
16.2.9. Redwood Toxicology Laboratory
16.2.9.1. Overview
16.2.9.2. Product Portfolio
16.2.9.3. Sales Footprint
16.2.9.4. Key Financials
16.2.9.5. SWOT Analysis
16.2.9.6. Strategy Overview
16.2.9.6.1. Marketing Strategy
16.2.9.6.2. Product Strategy
16.2.9.6.3. Channel Strategy
16.2.10. Laboratory Corporation of America ©Holdings (MedTox Laboratories, Inc.)
16.2.10.1. Overview
16.2.10.2. Product Portfolio
16.2.10.3. Sales Footprint
16.2.10.4. Key Financials
16.2.10.5. SWOT Analysis
16.2.10.6. Strategy Overview
16.2.10.6.1. Marketing Strategy
16.2.10.6.2. Product Strategy
16.2.10.6.3. Channel Strategy
16.2.11. Principle Laboratory
16.2.11.1. Overview
16.2.11.2. Product Portfolio
16.2.11.3. Sales Footprint
16.2.11.4. Key Financials
16.2.11.5. SWOT Analysis
16.2.11.6. Strategy Overview
16.2.11.6.1. Marketing Strategy
16.2.11.6.2. Product Strategy
16.2.11.6.3. Channel Strategy
16.2.12. Pacific Toxicology Laboratories
16.2.12.1. Overview
16.2.12.2. Product Portfolio
16.2.12.3. Sales Footprint
16.2.12.4. Key Financials
16.2.12.5. SWOT Analysis
16.2.12.6. Strategy Overview
16.2.12.6.1. Marketing Strategy
16.2.12.6.2. Product Strategy
16.2.12.6.3. Channel Strategy
16.2.13. Medical Toxicology Laboratory, LLC
16.2.13.1. Overview
16.2.13.2. Product Portfolio
16.2.13.3. Sales Footprint
16.2.13.4. Key Financials
16.2.13.5. SWOT Analysis
16.2.13.6. Strategy Overview
16.2.13.6.1. Marketing Strategy
16.2.13.6.2. Product Strategy
16.2.13.6.3. Channel Strategy
16.2.14. ITR Canada
16.2.14.1. Overview
16.2.14.2. Product Portfolio
16.2.14.3. Sales Footprint
16.2.14.4. Key Financials
16.2.14.5. SWOT Analysis
16.2.14.6. Strategy Overview
16.2.14.6.1. Marketing Strategy
16.2.14.6.2. Product Strategy
16.2.14.6.3. Channel Strategy
16.2.15. NMS Labs
16.2.15.1. Overview
16.2.15.2. Product Portfolio
16.2.15.3. Sales Footprint
16.2.15.4. Key Financials
16.2.15.5. SWOT Analysis
16.2.15.6. Strategy Overview
16.2.15.6.1. Marketing Strategy
16.2.15.6.2. Product Strategy
16.2.15.6.3. Channel Strategy
16.2.16. National Toxicology Labs, Inc
16.2.16.1. Overview
16.2.16.2. Product Portfolio
16.2.16.3. Sales Footprint
16.2.16.4. Key Financials
16.2.16.5. SWOT Analysis
16.2.16.6. Strategy Overview
16.2.16.6.1. Marketing Strategy
16.2.16.6.2. Product Strategy
16.2.16.6.3. Channel Strategy
16.2.17. BATTS Laboratories
16.2.17.1. Overview
16.2.17.2. Product Portfolio
16.2.17.3. Sales Footprint
16.2.17.4. Key Financials
16.2.17.5. SWOT Analysis
16.2.17.6. Strategy Overview
16.2.17.6.1. Marketing Strategy
16.2.17.6.2. Product Strategy
16.2.17.6.3. Channel Strategy
16.2.18. Marshfield Clinic
16.2.18.1. Overview
16.2.18.2. Product Portfolio
16.2.18.3. Sales Footprint
16.2.18.4. Key Financials
16.2.18.5. SWOT Analysis
16.2.18.6. Strategy Overview
16.2.18.6.1. Marketing Strategy
16.2.18.6.2. Product Strategy
16.2.18.6.3. Channel Strategy
16.2.19. TOTAL TOXICOLOGY LABS
16.2.19.1. Overview
16.2.19.2. Product Portfolio
16.2.19.3. Sales Footprint
16.2.19.4. Key Financials
16.2.19.5. SWOT Analysis
16.2.19.6. Strategy Overview
16.2.19.6.1. Marketing Strategy
16.2.19.6.2. Product Strategy
16.2.19.6.3. Channel Strategy
16.2.20. Clinical Reference Laboratory, Inc.
16.2.20.1. Overview
16.2.20.2. Product Portfolio
16.2.20.3. Sales Footprint
16.2.20.4. Key Financials
16.2.20.5. SWOT Analysis
16.2.20.6. Strategy Overview
16.2.20.6.1. Marketing Strategy
16.2.20.6.2. Product Strategy
16.2.20.6.3. Channel Strategy
16.2.21. Life Brite Labs.
16.2.21.1. Overview
16.2.21.2. Product Portfolio
16.2.21.3. Sales Footprint
16.2.21.4. Key Financials
16.2.21.5. SWOT Analysis
16.2.21.6. Strategy Overview
16.2.21.6.1. Marketing Strategy
16.2.21.6.2. Product Strategy
16.2.21.6.3. Channel Strategy
16.2.22. Product Safety Labs
16.2.22.1. Overview
16.2.22.2. Product Portfolio
16.2.22.3. Sales Footprint
16.2.22.4. Key Financials
16.2.22.5. SWOT Analysis
16.2.22.6. Strategy Overview
16.2.22.6.1. Marketing Strategy
16.2.22.6.2. Product Strategy
16.2.22.6.3. Channel Strategy
16.2.23. Lexar Labs
16.2.23.1. Overview
16.2.23.2. Product Portfolio
16.2.23.3. Sales Footprint
16.2.23.4. Key Financials
16.2.23.5. SWOT Analysis
16.2.23.6. Strategy Overview
16.2.23.6.1. Marketing Strategy
16.2.23.6.2. Product Strategy
16.2.23.6.3. Channel Strategy
16.2.24. Eurofins Scientific
16.2.24.1. Overview
16.2.24.2. Product Portfolio
16.2.24.3. Sales Footprint
16.2.24.4. Key Financials
16.2.24.5. SWOT Analysis
16.2.24.6. Strategy Overview
16.2.24.6.1. Marketing Strategy
16.2.24.6.2. Product Strategy
16.2.24.6.3. Channel Strategy
16.2.25. Aegis Sciences Corporation
16.2.25.1. Overview
16.2.25.2. Product Portfolio
16.2.25.3. Sales Footprint
16.2.25.4. Key Financials
16.2.25.5. SWOT Analysis
16.2.25.6. Strategy Overview
16.2.25.6.1. Marketing Strategy
16.2.25.6.2. Product Strategy
16.2.25.6.3. Channel Strategy
16.2.26. Enzo Life Sciences, Inc.
16.2.26.1. Overview
16.2.26.2. Product Portfolio
16.2.26.3. Sales Footprint
16.2.26.4. Key Financials
16.2.26.5. SWOT Analysis
16.2.26.6. Strategy Overview
16.2.26.6.1. Marketing Strategy
16.2.26.6.2. Product Strategy
16.2.26.6.3. Channel Strategy
16.2.27. Immunalysis Corporation
16.2.27.1. Overview
16.2.27.2. Product Portfolio
16.2.27.3. Sales Footprint
16.2.27.4. Key Financials
16.2.27.5. SWOT Analysis
16.2.27.6. Strategy Overview
16.2.27.6.1. Marketing Strategy
16.2.27.6.2. Product Strategy
16.2.27.6.3. Channel Strategy
16.2.28. Vala Sciences, Inc.
16.2.28.1. Overview
16.2.28.2. Product Portfolio
16.2.28.3. Sales Footprint
16.2.28.4. Key Financials
16.2.28.5. SWOT Analysis
16.2.28.6. Strategy Overview
16.2.28.6.1. Marketing Strategy
16.2.28.6.2. Product Strategy
16.2.28.6.3. Channel Strategy
16.2.29. Mattek Corporation
16.2.29.1. Overview
16.2.29.2. Product Portfolio
16.2.29.3. Sales Footprint
16.2.29.4. Key Financials
16.2.29.5. SWOT Analysis
16.2.29.6. Strategy Overview
16.2.29.6.1. Marketing Strategy
16.2.29.6.2. Product Strategy
16.2.29.6.3. Channel Strategy
16.2.30. MedTest Dx
16.2.30.1. Overview
16.2.30.2. Product Portfolio
16.2.30.3. Sales Footprint
16.2.30.4. Key Financials
16.2.30.5. SWOT Analysis
16.2.30.6. Strategy Overview
16.2.30.6.1. Marketing Strategy
16.2.30.6.2. Product Strategy
16.2.30.6.3. Channel Strategy
16.2.31. Pyxis Laboratories Inc
16.2.31.1. Overview
16.2.31.2. Product Portfolio
16.2.31.3. Sales Footprint
16.2.31.4. Key Financials
16.2.31.5. SWOT Analysis
16.2.31.6. Strategy Overview
16.2.31.6.1. Marketing Strategy
16.2.31.6.2. Product Strategy
16.2.31.6.3. Channel Strategy
16.2.32. Air Science® USA LLC
16.2.32.1. Overview
16.2.32.2. Product Portfolio
16.2.32.3. Sales Footprint
16.2.32.4. Key Financials
16.2.32.5. SWOT Analysis
16.2.32.6. Strategy Overview
16.2.32.6.1. Marketing Strategy
16.2.32.6.2. Product Strategy
16.2.32.6.3. Channel Strategy
17. Assumptions and Acronyms Used
18. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Drug Class
Table 02: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Product
Table 03: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Sample
Table 04: North America Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by End User
Table 05: North America Toxicology Laboratories Market Value (US$ Mn) Analysis 2016-2023 and Forecast 2023-2033, by Country
Table 06: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Drug Class
Table 07: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Product
Table 08: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Sample
Table 09: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by End User
Table 10: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Drug Class
Table 11: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Product
Table 12: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by Sample
Table 13: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis and Forecast 2016-2033, by End User
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: North America Toxicology Laboratories Market Value (US$ Mn) Analysis, 2016-2022
Figure 02: North America Toxicology Laboratories Market Forecast & Y-o-Y Growth, 2023-2033
Figure 03: North America Toxicology Laboratories Market Absolute $ Opportunity (US$ Mn) Analysis, 2023-2033
Figure 04: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Drug Class
Figure 05: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Drug Class
Figure 06: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Drug Class
Figure 07: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Product
Figure 08: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Product
Figure 09: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Product
Figure 10: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Sample
Figure 11: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Sample
Figure 12: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Sample
Figure 13: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by End User
Figure 14: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by End User
Figure 15: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by End User
Figure 16: North America Toxicology Laboratories Market Value Share (%) Analysis 2023 and 2033, by Country
Figure 17: North America Toxicology Laboratories Market Y-o-Y Growth (%) Analysis 2023-2033, by Country
Figure 18: North America Toxicology Laboratories Market Attractiveness Analysis 2023-2033, by Country
Figure 19: U.S. Toxicology Laboratories Market Value (US$ Mn) Analysis, 2016-2022
Figure 20: U.S. Toxicology Laboratories Market Value (US$ Mn) Forecast, 2023-2033
Figure 21: U.S. Toxicology Laboratories Market Value Share, By Drug Class (2023 E)
Figure 22: U.S. Toxicology Laboratories Market Value Share, By Product (2023 E)
Figure 23: U.S. Toxicology Laboratories Market Value Share, By Sample (2023 E)
Figure 24: U.S. Toxicology Laboratories Market Value Share, By End User (2023 E)
Figure 25: U.S. Toxicology Laboratories Market Attractiveness Analysis By Drug Class, 2023-2033
Figure 26: U.S. Toxicology Laboratories Market Attractiveness Analysis By Product, 2023-2033
Figure 27: U.S. Toxicology Laboratories Market Attractiveness Analysis By Sample, 2023-2033
Figure 28: U.S. Toxicology Laboratories Market Attractiveness Analysis By End User, 2023-2033
Figure 29: Canada Toxicology Laboratories Market Value (US$ Mn) Analysis, 2016-2022
Figure 30: Canada Toxicology Laboratories Market Value (US$ Mn) Forecast, 2023-2033
Figure 31: Canada Toxicology Laboratories Market Value Share, By Drug Class (2023 E)
Figure 32: Canada Toxicology Laboratories Market Value Share, By Product (2023 E)
Figure 33: Canada Toxicology Laboratories Market Value Share, By Sample (2023 E)
Figure 34: Canada Toxicology Laboratories Market Value Share, By End User (2023 E)
Figure 35: Canada Toxicology Laboratories Market Attractiveness Analysis By Drug Class, 2023-2033
Figure 36: Canada Toxicology Laboratories Market Attractiveness Analysis By Product, 2023-2033
Figure 37: Canada Toxicology Laboratories Market Attractiveness Analysis By Sample, 2023-2033
Figure 38: Canada Toxicology Laboratories Market Attractiveness Analysis By End User, 2023-2033
